These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 2399887
21. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans. Kidwell GA, Greenspon AJ, Greenberg RM, Volosin KJ. Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998 [Abstract] [Full Text] [Related]
23. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia. Man KC, Williamson BD, Niebauer M, Daoud E, Bakr O, Strickberger SA, Hummel JD, Kou W, Morady F. Am J Cardiol; 1994 Dec 01; 74(11):1119-23. PubMed ID: 7977070 [Abstract] [Full Text] [Related]
24. Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide. Windle J, Prystowsky EN, Miles WM, Heger JJ. Clin Pharmacol Ther; 1987 Jun 01; 41(6):603-10. PubMed ID: 3581646 [Abstract] [Full Text] [Related]
28. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy. Rae AP, Sokoloff NM, Webb CR, Spielman SR, Greenspan AM, Horowitz LN. J Am Coll Cardiol; 1985 Aug 01; 6(2):410-6. PubMed ID: 4019928 [Abstract] [Full Text] [Related]
29. Termination of ventricular tachycardia: role of tachycardia cycle length. Roy D, Waxman HL, Buxton AE, Marchlinski FE, Cain ME, Gardner MJ, Josephson ME. Am J Cardiol; 1982 Dec 01; 50(6):1346-50. PubMed ID: 7148712 [Abstract] [Full Text] [Related]
31. Amiodarone therapy: role of early and late electrophysiologic studies. Greenspon AJ, Volosin KJ, Greenberg RM, Jefferies L, Rotmensch HH. J Am Coll Cardiol; 1988 Jan 01; 11(1):117-23. PubMed ID: 3335688 [Abstract] [Full Text] [Related]
33. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia. Marchlinski FE, Buxton AE, Miller JM, Vassallo JA, Flores BT, Josephson ME. Circulation; 1986 Nov 01; 74(5):1037-43. PubMed ID: 3769163 [Abstract] [Full Text] [Related]
34. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease. Pires LA, Wagshal AB, Greene TO, Mittleman RS, Huang SK. Am J Cardiol; 1993 Oct 15; 72(12):908-10. PubMed ID: 8105674 [Abstract] [Full Text] [Related]
35. Amiodarone: correlation of early and late electrophysiologic studies with outcome. Kadish AH, Marchlinski FE, Josephson ME, Buxton AE. Am Heart J; 1986 Dec 15; 112(6):1134-40. PubMed ID: 3788759 [Abstract] [Full Text] [Related]
39. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease. Friehling TD, Lipshutz H, Marinchak RA, Stohler JL, Kowey PR. Am J Cardiol; 1990 Jun 01; 65(20):1328-33. PubMed ID: 2343820 [Abstract] [Full Text] [Related]